In the latest trading session,, 17.89 million Artelo Biosciences Inc (NASDAQ:ARTL) shares changed hands as the company’s beta touched 1.05. With the company’s most recent per share price at $20.28 changing hands around $13.49 or 198.75% at last look, the market valuation stands at $11.08M. ARTL’s last price was a premium, traded about 54.14% off its 52-week high of $9.30. The share price had its 52-week low at $4.92, which suggests the last value was 75.74% up since then. When we look at Artelo Biosciences Inc’s average trading volume, we note the 10-day average is 15970.0 shares, with the 3-month average coming to 71.42K.
Analysts gave the Artelo Biosciences Inc (ARTL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ARTL as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Artelo Biosciences Inc (NASDAQ:ARTL) trade information
Instantly ARTL is in green as seen in intraday trades today. With action 244.98%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 151.27%, with the 5-day performance at 244.98% in the green. However, in the 30-day time frame, Artelo Biosciences Inc (NASDAQ:ARTL) is 233.09% up. Looking at the short shares, we see there were 11794.0 shares sold at short interest cover period of 1.0 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -24.98%. The 2025 estimates are for Artelo Biosciences Inc earnings to increase by 64.59%, but the outlook for the next 5-year period is at 48.77% per year.
ARTL Dividends
Artelo Biosciences Inc is expected to release its next quarterly earnings report on 2025-May-13.
Artelo Biosciences Inc (NASDAQ:ARTL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.81% of Artelo Biosciences Inc shares while 2.64% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.66%.
